Brainowl’s ‘Free’ IQ Test
“Free” offer could prove costly.
Fust et al. v. Gilead Sciences, Inc.
23-at-1244, E.D. Cal.
(Sept. 2023)
Remdesivir
Falsely marketing Remdesivir as safe and effective against COVID-19 without disclosing its limitations and adverse events, including fatalities
Pending
“Free” offer could prove costly.
The cat’s out the (red) bag.
Company’s animal welfare claims – and brand name – face increasing scrutiny.
Consumers balk at hidden junk fees.
TINA.org uncovers the limits of this carrier’s “unlimited” data plans.